Zilsun MR 12,5 mg Tablet
PDF Leaflet Revision Date: 03 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of severe insomnia in adults under 65.
Dosage (summary)
12.5 mg once daily before bedtime; max duration 4 weeks.
Onset of Action / Duration
Onset: Rapid, Duration: 7-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Alcohol
- CNS depressants
- Opioids
- Fluvoxamine
- Ciprofloxacin
Contraindications
- Hypersensitivity
- Children under 18
- Sleep apnoea
- Severe hepatic impairment
- Acute respiratory impairment
Common side effects
- Drowsiness
- Dizziness
- Headache
- Nausea
- Amnesia
Counselling Points
- Take immediately before bedtime
- Avoid alcohol
- Do not drive after use
- Report unusual behaviors
Serious warnings
- Risk of dependence
- Respiratory depression
- Amnesia
- Paradoxical reactions
Important Disclaimer
The Zilsun MR 12,5 mg Tablet professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
